Małgorzata Wrzosek

Pseudomonas aeruginosa is a major opportunistic pathogen whose adaptive capacity limits the long-term efficacy of antibiotic therapy. Beyond classical resistance mechanisms, antibiotics may also act as stress signals that alter bacterial physiology and evolutionary trajectories. A central element of this response is the SOS regulatory network, controlled by the RecA–LexA system. Although well studied in Escherichia coli, SOS signaling in P. aeruginosa shows distinct regulatory features that remain incompletely understood. This review summarizes experimental and clinical evidence on antibiotic-induced SOS responses in P. aeruginosa, focusing on fluoroquinolones and other genotoxic agents. Fluoroquinolone exposure consistently induces SOS activation and RecA-dependent signaling, affecting short-term antibiotic susceptibility. However, the available evidence does not support a universal role for SOS activation as a major driver of long-term resistance evolution under most tested conditions. Its relationship with antibiotic-induced mutagenesis remains variable: some studies implicate low-fidelity DNA polymerases, whereas others report mutagenesis independent of canonical RecA–LexA control. Beyond mutagenesis, SOS activation may affect integron dynamics, virulence, and biofilm-associated phenotypes. Overall, in P. aeruginosa, the SOS response appears to be a context-dependent modulator of stress adaptation rather than a universal determinant of resistance evolution.

Background/Objectives: Chronic lower-limb ulcers of mixed etiology are characterized by impaired microcirculation and persistent inflammation, leading to delayed healing, frequent hospitalizations, and a high risk of limb loss. While infrared thermography reflects local perfusion status and systemic inflammatory markers capture whole-body immune activation, these dimensions are usually assessed separately. The objective of this study was to develop and internally evaluate a composite Thermal–Inflammatory Index (TI) integrating wound-bed thermography with systemic inflammatory markers to stratify disease severity and prognosis in patients with chronic lower-limb ulcers. Methods: In this prospective observational study, 82 adults with chronic lower-limb ulcers underwent baseline infrared thermographic assessment of wound-bed temperature using a standardized protocol. Concurrently, neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) were measured. The Thermal–Inflammatory Index was constructed as a standardized composite of inverted wound-bed temperature, NLR, and CRP. A simplified TI score (0–3) was derived using predefined clinical thresholds. The primary endpoint was a composite adverse outcome defined as amputation or failure to achieve complete wound healing within 12 weeks. Secondary outcomes included a prolonged hospital stay (>7 days). Discriminative performance was assessed using receiver operating characteristic analysis, and associations were examined using correlation and logistic regression models. Results: Higher TI values were associated with colder wound beds, elevated systemic inflammatory markers, and increased disease burden. The TI demonstrated moderate discrimination for the composite adverse outcome (AUC 0.75) and prolonged hospitalization (AUC 0.71), performing comparably to the strongest single component (−T_bed, AUC 0.77) while integrating local and systemic information. Each one-standard-deviation increase in TI was independently associated with higher odds of the composite adverse outcome and a prolonged hospital stay. The simplified TI score showed clear stepwise gradients in adverse outcomes and length of hospitalization. Conclusions: The Thermal–Inflammatory Index integrates thermographic and inflammatory signals into a single, clinically interpretable biomarker of severity and prognosis in chronic lower-limb ulcers. TI and the simplified TI score may support early risk stratification using low-cost, bedside-accessible data.

S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) are essential intermediates in one-carbon metabolism and key regulators of cellular methylation capacity. Their concentrations and the SAM/SAH ratio are increasingly studied as biomarkers across metabolic, cardiovascular, neurological, and cancer-related diseases. This review outlines validated analytical methods for quantifying SAM and SAH, focusing primarily on liquid chromatography–tandem mass spectrometry (LC–MS/MS), which is considered the gold standard in both clinical and research settings. A comprehensive literature search identified studies on method development, validation, and clinical use of SAM and SAH measurements. Special attention is given to analytical challenges arising from their high polarity, structural similarity, endogenous presence, and limited stability. The review also discusses preanalytical variables, including biological matrix selection, sample handling, and storage conditions. LC–MS/MS methods are compared with alternative techniques, such as immunoassays, with respect to sensitivity, specificity, matrix effects, and clinical relevance. Additionally, the review summarizes the concentration ranges of SAM and SAH, and their ratio, in healthy and patient populations, noting current standardization limitations. Overall, the review highlights the importance of harmonized analytical protocols and matrix-specific validation to enable reliable clinical interpretation of SAM and SAH as methylation biomarkers.

Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, remain a major global healthcare challenge, associated with substantial morbidity, risk of limb loss, and high healthcare costs. Increasing evidence indicates that the wound microbiome modulates inflammation, tissue repair, and responses to therapy, thereby influencing clinical outcomes. This review summarizes current knowledge on the composition and function of chronic wound microbial communities and discusses their clinical relevance as prognostic biomarkers and therapeutic targets. Microbiome structure is shaped by wound etiology, chronicity, anatomical site, and host comorbidities. Dysbiosis and biofilm formation contribute to persistent inflammation, antimicrobial tolerance, and delayed healing. Advances in sequencing and multi-omics technologies have improved microbial characterization and enabled the identification of candidate microbial signatures associated with healing trajectories. Emerging microbiome-modulating strategies such as probiotics, bacteriophages, topical oxygen approaches, and nanotechnology-based interventions show potential to shift wound ecosystems toward a pro-healing state; however, robust clinical validation remains limited. Further clinical studies are needed to validate microbiome-guided diagnostics and interventions and to establish standardized protocols for their application in clinical practice.

This study investigated the phytochemical composition and biological activity of Cymbopogon citratus microshoot cultures and evaluated their suitability for incorporation into a cosmetic formulation. Microshoot cultures were established on Murashige and Skoog media supplemented with plant growth regulators and served as a reproducible source of biomass. Methanolic and ethanolic extracts were analyzed for total phenolic content (TPC), total flavonoid content (TFC), and antioxidant activity using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assays. Chemical composition was characterized using LC-MS/MS analysis, which revealed the presence of phenolic acids and flavonoids, with p-coumaric, caffeic, and ferulic acids being among the most abundant detected constituents. In biological assays, the extracts inhibited murine tyrosinase in a concentration-dependent manner and exhibited antimicrobial activity against selected oral and skin-associated microorganisms, including Streptococcus mutans, Streptococcus pyogenes, and Staphylococcus epidermidis, as well as showing fungistatic and fungicidal effects against Candida albicans. Cytotoxicity analysis performed on HaCaT keratinocytes confirmed biocompatibility within the tested concentration range. To assess formulation suitability, the microshoot extract was incorporated into an oil-in-water (O/W) cream, which maintained stable pH, viscosity, and physical properties while preserving the antioxidant activity of the extract. Overall, these findings indicate that C. citratus microshoot cultures represent a reproducible source of bioactive metabolites with potential application in cosmetic formulations.

Introduction:Diabetic foot infection (DFI) is a major complication of diabetes associated with high rates of amputation, recurrence, and healthcare utilization. The prognostic interaction between clinical and microbiological markers remains unclear.Material and methods:We retrospectively analyzed 121 hospitalizations of 86 patients treated surgically for DFI (2021–2025). Clinical, laboratory, and microbiological variables were assessed in relation to amputation, reamputation, rehospitalization, length of stay (LOS), and mortality.Results:Amputation was performed in 72/121 episodes (59.5%), including 57 minor and 15 major procedures. Reamputation occurred in 13/121 cases (10.7%). Rehospitalization was recorded in 42/86 patients (48.8%). Median LOS was 13 days (IQR 8–21). A total of 227 isolates were obtained, with Enterococcus faecalis (38 isolates, 16.7%) and Staphylococcus aureus (28 isolates, 12.3%) being the most frequent. Polymicrobial infections were present in 75/121 episodes (63%). Neuro-ischemic ulcer phenotype independently predicted reamputation (aOR 3.72; p=0.036). Staphylococcaceae increased the likelihood of rehospitalization (aOR 3.32; p=0.014). NLR >5 prolonged LOS by 42%, and Enterococcus spp. by 51%. Repeat hospitalizations showed enrichment of ESBL Klebsiella pneumoniae (5 cases) and HLAR E. faecalis (9 cases).Conclusions:Ulcer phenotype and systemic inflammatory response were the strongest predictors of adverse outcomes. Microbiology contributed selective yet clinically meaningful prognostic information, particularly regarding Staphylococcaceae and Enterococcus spp.Keywords: diabetic foot infection, microbiological profile, Enterococcus, ulcer phenotype, inflammatory markers.

Biscutella laevigata (Brassicaceae) is an endemic species confined to European mountain regions, with a distribution range extending from the Iberian Peninsula through the Carpathians to the Balkans. The objective of this study was to investigate the phytochemical composition and biological properties of extracts obtained from leaves, seeds, and in vitro-derived microshoot cultures. UHPLC-DAD-MS/MS profiling of glucosinolates (GSLs) revealed six compounds exclusively present in seed extracts, with glucohirsutin identified as the predominant constituent (15.06 mg/100 g DW). No glucosinolates were detected in either leaf or microshoot extracts. Notably, 8-(methylsulfonyl)octyl GSL was reported in B. laevigata for the first time. The seed extract exhibited the highest total polyphenol content (TPC, 25,701.00 mg GAE/100 g DW), while leaf and microshoot extracts contained similar amounts (16,244.00 and 16,552.00 mg GAE/100 g DW, respectively). Among phenolic compounds, rutin was the most abundant, reaching up to 1609.21 mg/100 g DW in leaf extracts. Antioxidant capacity, assessed by ABTS and DPPH assays, was strongest in the seed extract (90.56% and 69.24% inhibition, respectively). The same extract demonstrated the greatest anti-elastase activity (12.68%), whereas the microshoot extract displayed a considerable Fe²⁺-chelating ability (12.48%). All tested extracts showed antimicrobial potential against Staphylococcus aureus, Escherichia coli, Cutibacterium acnes, and the fungus Candida albicans.

Carboxytherapy is a non-invasive therapeutic method involving the transcutaneous or subcutaneous administration of carbon dioxide (CO₂), which stimulates microcirculation, neoangiogenesis, and collagen production. This narrative review summarizes the latest scientific findings (2020–2025) on the effectiveness of carboxytherapy in treating selected dermatological and aesthetic skin conditions, including periorbital dark circles, stretch marks, scars, and signs of skin aging. The article discusses both monotherapies and combination protocols, particularly with laser therapies and chemical peels. Numerous clinical studies confirm that carboxytherapy significantly improves skin elasticity, tone, hydration, and structure through mechanisms such as improved oxygenation, stimulation of fibroblasts, and controlled inflammation. Moreover, combination therapies frequently offer superior outcomes, especially in scar and stretch mark reduction. Carboxytherapy demonstrates high safety, minimal side effects, and broad applicability, making it a valuable tool in both medical and cosmetic dermatology.

Nasturtium officinale R. Br. (watercress) is an endangered species with valuable pharmaceutical, cosmetic, and nutritional properties. The purpose of this work was to evaluate the phytochemical profile and biological activity of extracts from microshoot cultures grown in PlantForm bioreactors and the parent plant material. After 20 days of cultivation, the cultures achieved the best results both in terms of key active ingredient content and biological activity. The glucosinolates (GSL) profile by the UHPLC-DAD-MS/MS method showed that the dominant compounds were glucobrassicin (493.00 mg/100 g DW, 10 days) and gluconasturtiin (268.04 mg/100 g DW, 20 days). The highest total polyphenol content (TPC) was obtained after a 20-day growth period (2690 mg GAE/100 g DW). Among polyphenols, the dominant compounds in the extracts from in vitro cultures were sinapinic acid (114.83 mg/100 g DW, 10 days) and ferulic acid (87.78 mg/100 g DW, 20 days). The highest antioxidant potential assessed by ABTS and DPPH assays was observed for ethanol extracts. The best results for inhibiting hyperpigmentation (18.12%) were obtained for ethanol extracts and anti-elastase activity (79.78%) for aqueous extract from N. officinale microshoot cultures. The extracts from microshoot cultures inhibited the growth of bacteria, including Cutibacterium acnes (MIC = 0.625 mg/mL). Antioxidant tests and the chelating capacity of iron ions Fe²⁺ of the face emulsion with N. officinale extracts showed higher results than the control.

The aim of this review is to analyze natural substances exhibiting antibacterial and antifungal activity against skin pathogens, along with their exemplary applications in cosmetic products. Growing concerns related to increasing infection rates and pathogen resistance have prompted the search for alternative therapeutic methods. This article discusses various natural products, derived from plants, animals, and minerals, with antimicrobial potential. Special attention is given to the antimicrobial efficacy of natural substances derived from Allium L., Salvia L., Lavandula L., Origanum L., Melaleuca alternifolia, Aloe vera, Black Cumin, and Trigonella L. in improving treatment outcomes, either alone or in combination with conventional medications. In addition, the presented natural products, such as propolis, honey, cosmetic mud, and clays, can serve as viable alternatives or complementary treatments for mild skin infections and may help prevent recurrence. The promising potential of these natural products encourages further research into discovering new antimicrobial agents. However, the lack of standardization of natural preparations can result in inconsistent therapeutic effects and unforeseen side effects. This review significantly contributes to the pharmaceutical and cosmetic industries by emphasizing the potential of natural products and highlighting the need for further research and regulatory measures to ensure their safe and effective integration with existing therapies.